OPKO Health, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
OPKO Health, Inc. (OPK) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$65.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2026-08-28
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-06-30 was -$65.00K, a 506.25% decline year-over-year.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-03-31 was -$298.00K.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-12-31 was -$134.00K.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-09-30 was -$38.00K.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2025 was -$429.00K.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2024 was -$26.16M.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was -$781.00K, a 220.34% decline from fiscal 2022.
- OPKO Health, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2022 was $649.00K, a 23.29% decline from fiscal 2021.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$65.00K 10-Q/A · filed 2026-08-28 | -$363.00K 10-Q/A · filed 2026-08-28 | -$497.00K derived: sum of 3 quarters · filed 2026-08-28 | -$535.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | -$298.00K 10-Q/A · filed 2026-08-28 | -$432.00K derived: sum of 2 quarters · filed 2026-08-28 | -$470.00K derived: sum of 3 quarters · filed 2026-08-28 | -$454.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$172.00K derived: sum of 2 quarters · filed 2026-02-26 | -$156.00K derived: sum of 3 quarters · filed 2026-08-28 | -$429.00K 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$38.00K 10-Q · filed 2025-10-29 | -$22.00K derived: sum of 2 quarters · filed 2026-08-28 | -$295.00K 10-Q · filed 2025-10-29 | -$295.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | $16.00K 10-Q/A · filed 2026-08-28 | -$257.00K 10-Q/A · filed 2026-08-28 | -$257.00K derived: sum of 3 quarters · filed 2026-08-28 | -$258.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | -$273.00K 10-Q/A · filed 2026-08-28 | -$273.00K derived: sum of 2 quarters · filed 2026-08-28 | -$274.00K derived: sum of 3 quarters · filed 2026-08-28 | -$273.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.00K derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | -$26.16M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$1.00K 10-Q · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | -$26.16M 10-Q · filed 2025-10-29 | -$26.11M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.00K 10-Q · filed 2025-07-31 | -$26.16M 10-Q · filed 2025-07-31 | -$26.11M derived: sum of 3 quarters · filed 2026-02-26 | -$26.02M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$26.16M 10-Q · filed 2025-05-01 | -$26.11M derived: sum of 2 quarters · filed 2026-02-26 | -$26.02M derived: sum of 3 quarters · filed 2026-02-26 | -$25.88M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $136.00K derived: sum of 2 quarters · filed 2026-02-26 | $278.00K derived: sum of 3 quarters · filed 2026-02-26 | -$781.00K 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $88.00K 10-Q · filed 2024-11-07 | $230.00K derived: sum of 2 quarters · filed 2024-11-07 | -$829.00K 10-Q · filed 2024-11-07 | -$832.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $142.00K 10-Q · filed 2024-08-07 | -$917.00K 10-Q · filed 2024-08-07 | -$920.00K derived: sum of 3 quarters · filed 2025-03-03 | -$474.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | -$1.06M 10-Q · filed 2024-05-07 | -$1.06M derived: sum of 2 quarters · filed 2025-03-03 | -$616.00K derived: sum of 3 quarters · filed 2025-03-03 | -$278.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $443.00K derived: sum of 2 quarters · filed 2025-03-03 | $781.00K derived: sum of 3 quarters · filed 2025-03-03 | $649.00K 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $446.00K 10-Q · filed 2023-11-06 | $784.00K derived: sum of 2 quarters · filed 2023-11-06 | $652.00K 10-Q · filed 2023-11-06 | $927.00K derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2022-06-30 | $338.00K 10-Q · filed 2023-08-03 | $206.00K 10-Q · filed 2023-08-03 | $481.00K derived: sum of 3 quarters · filed 2024-03-01 | $1.76M derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2022-03-31 | -$132.00K 10-Q · filed 2023-05-03 | $143.00K derived: sum of 2 quarters · filed 2024-03-01 | $1.43M derived: sum of 3 quarters · filed 2024-03-01 | $1.15M derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2021-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $1.56M derived: sum of 2 quarters · filed 2024-03-01 | $1.29M derived: sum of 3 quarters · filed 2024-03-01 | $846.00K 10-K · filed 2024-03-01 | ||||
| 2021-09-30 | $1.28M 10-Q · filed 2022-11-08 | $1.01M derived: sum of 2 quarters · filed 2022-11-08 | $571.00K 10-Q · filed 2022-11-08 | $510.00K derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | -$272.00K 10-Q · filed 2022-08-04 | -$711.00K 10-Q · filed 2022-08-04 | -$773.00K derived: sum of 3 quarters · filed 2023-02-27 | -$1.27M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$439.00K 10-Q · filed 2022-05-09 | -$501.00K derived: sum of 2 quarters · filed 2023-02-27 | -$997.00K derived: sum of 3 quarters · filed 2023-02-27 | -$1.01M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$558.00K derived: sum of 2 quarters · filed 2023-02-27 | -$571.00K derived: sum of 3 quarters · filed 2023-02-27 | $50.00K 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | -$496.00K 10-Q · filed 2021-10-28 | -$509.00K derived: sum of 2 quarters · filed 2021-10-28 | $112.00K 10-Q · filed 2021-10-28 | $280.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$13.00K 10-Q · filed 2021-07-29 | $608.00K 10-Q · filed 2021-07-29 | $776.00K derived: sum of 3 quarters · filed 2022-03-01 | $755.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $621.00K 10-Q · filed 2021-04-28 | $789.00K derived: sum of 2 quarters · filed 2022-03-01 | $768.00K derived: sum of 3 quarters · filed 2022-03-01 | $380.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $147.00K derived: sum of 2 quarters · filed 2022-03-01 | -$241.00K derived: sum of 3 quarters · filed 2022-03-01 | $174.00K 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$21.00K 10-Q · filed 2020-10-29 | -$409.00K derived: sum of 2 quarters · filed 2020-10-29 | $6.00K 10-Q · filed 2020-10-29 | -$440.00K derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-06-30 | -$388.00K 10-Q · filed 2020-07-31 | $27.00K 10-Q · filed 2020-07-31 | -$419.00K derived: sum of 3 quarters · filed 2021-02-18 | -$574.00K derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-03-31 | $415.00K 10-Q · filed 2020-05-06 | -$31.00K derived: sum of 2 quarters · filed 2021-02-18 | -$186.00K derived: sum of 3 quarters · filed 2021-02-18 | $2.06M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2018-12-31 | -$446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$601.00K derived: sum of 2 quarters · filed 2021-02-18 | $1.65M derived: sum of 3 quarters · filed 2021-02-18 | $3.04M 10-K · filed 2021-02-18 | ||||
| 2018-09-30 | -$155.00K 10-Q · filed 2019-11-05 | $2.09M derived: sum of 2 quarters · filed 2019-11-05 | $3.49M 10-Q · filed 2019-11-05 | $1.57M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $2.25M 10-Q · filed 2019-08-07 | $3.64M 10-Q · filed 2019-08-07 | $1.73M derived: sum of 3 quarters · filed 2020-03-02 | -$5.82M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $1.40M 10-Q · filed 2019-05-08 | -$521.00K derived: sum of 2 quarters · filed 2020-03-02 | -$8.07M derived: sum of 3 quarters · filed 2020-03-02 | -$2.59M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$9.47M derived: sum of 2 quarters · filed 2020-03-02 | -$3.98M derived: sum of 3 quarters · filed 2020-03-02 | $52.00K 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$7.55M 10-Q · filed 2018-11-09 | -$2.07M derived: sum of 2 quarters · filed 2018-11-09 | $1.97M 10-Q · filed 2018-11-09 | $10.64M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $5.48M 10-Q · filed 2018-08-07 | $9.52M 10-Q · filed 2018-08-07 | $18.19M derived: sum of 3 quarters · filed 2019-03-01 | $12.48M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $4.04M 10-Q · filed 2018-05-08 | $12.70M derived: sum of 2 quarters · filed 2019-03-01 | $7.00M derived: sum of 3 quarters · filed 2019-03-01 | $8.24M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $8.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.97M derived: sum of 2 quarters · filed 2019-03-01 | $4.20M derived: sum of 3 quarters · filed 2019-03-01 | $2.78M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$5.70M 10-Q · filed 2017-11-08 | -$4.47M derived: sum of 2 quarters · filed 2017-11-08 | -$5.89M 10-Q · filed 2017-11-08 | -$10.87M derived: sum of 4 quarters · filed 2019-01-29 | ||||
| 2016-06-30 | $1.24M 10-Q · filed 2017-08-08 | -$188.00K 10-Q · filed 2017-08-08 | -$5.17M derived: sum of 3 quarters · filed 2019-01-29 | $27.07M derived: sum of 4 quarters · filed 2019-01-29 | ||||
| 2016-03-31 | -$1.42M 10-Q · filed 2017-05-10 | -$6.41M derived: sum of 2 quarters · filed 2019-01-29 | $25.84M derived: sum of 3 quarters · filed 2019-01-29 | $9.28M derived: sum of 4 quarters · filed 2019-01-29 | ||||
| 2015-12-31 | -$4.98M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $27.26M derived: sum of 2 quarters · filed 2019-01-29 | $10.71M derived: sum of 3 quarters · filed 2019-01-29 | -$39.08M 8-K · filed 2019-01-29 | ||||
| 2015-09-30 | $32.24M 10-Q · filed 2016-11-07 | $15.69M derived: sum of 2 quarters · filed 2016-11-07 | -$34.10M 10-Q · filed 2016-11-07 | -$48.49M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | -$16.56M 10-Q · filed 2016-08-08 | -$66.34M 10-Q · filed 2016-08-08 | -$80.73M derived: sum of 3 quarters · filed 2017-03-01 | -$77.43M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | -$49.79M 10-Q · filed 2016-05-09 | -$64.18M derived: sum of 2 quarters · filed 2017-03-01 | -$60.87M derived: sum of 3 quarters · filed 2017-03-01 | -$49.91M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$14.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$11.09M derived: sum of 2 quarters · filed 2017-03-01 | -$118.00K derived: sum of 3 quarters · filed 2017-03-01 | -$10.63M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $3.31M 10-Q · filed 2015-11-09 | $14.27M derived: sum of 2 quarters · filed 2015-11-09 | $3.76M 10-Q · filed 2015-11-09 | $6.31M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $10.97M 10-Q · filed 2015-08-05 | $594.00K 10-Q · filed 2015-08-05 | $452.00K 10-Q · filed 2014-08-11 | $3.00M derived: sum of 3 quarters · filed 2016-02-29 | -$34.45M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$10.37M 10-Q · filed 2015-05-11 | -$10.52M 10-Q · filed 2014-05-09 | -$7.96M derived: sum of 2 quarters · filed 2016-02-29 | -$45.42M derived: sum of 3 quarters · filed 2016-02-29 | -$32.77M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$35.04M derived: sum of 2 quarters · filed 2016-02-29 | -$22.39M derived: sum of 3 quarters · filed 2016-02-29 | -$45.94M 10-K · filed 2016-02-29 | -$36.49M 10-K · filed 2014-03-03 | |||
| 2013-09-30 | -$37.45M 10-Q · filed 2014-11-07 | -$27.79M 10-Q · filed 2013-11-12 | -$24.80M derived: sum of 2 quarters · filed 2014-11-07 | -$48.35M 10-Q · filed 2014-11-07 | -$38.69M 10-Q · filed 2013-11-12 | -$48.44M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $12.65M 10-Q · filed 2014-08-11 | -$10.90M 10-Q · filed 2014-08-11 | -$10.99M derived: sum of 3 quarters · filed 2015-02-27 | -$10.82M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | -$23.55M 10-Q · filed 2014-05-09 | -$23.64M derived: sum of 2 quarters · filed 2015-02-27 | -$23.47M derived: sum of 3 quarters · filed 2015-02-27 | |||||
| 2012-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $78.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.22M 10-K · filed 2015-02-27 | $1.34M 10-K · filed 2014-03-03 | ||||
| 2012-09-30 | $169.00K 10-Q · filed 2013-11-12 | $1.31M 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | -$39.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |